Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
05/05/2023 | HALOZYME THERAPEUTICS, INC. | HALO | Grant | Common Stock | 8.1k | $0.00 | $0 | | 05/05/2023 |
05/05/2023 | HALOZYME THERAPEUTICS, INC. | HALO | Grant | Option to Purchase Common Stock | 11.4k | $31.00 | $352.5k | | 05/05/2023 |
02/23/2023 | Ovid Therapeutics Inc. | OVID | Grant | Stock Option (Right to Buy) | 15k | $2.50 | $37.5k | | 02/23/2023 |
02/03/2023 | HALOZYME THERAPEUTICS, INC. | HALO | Grant | Common Stock | 1.2k | $0.00 | $0 | | 02/03/2023 |
07/01/2022 | Adaptimmune Therapeutics PLC | ADAP | Grant | Option to purchase Ordinary Shares | 500k | $0.00 | $0 | | 07/01/2022 |
06/24/2022 | Jounce Therapeutics, Inc. | JNCE | Grant | Stock Option (Right to Buy) | 20k | $2.80 | $56k | | 06/24/2022 |
06/17/2022 | Atea Pharmaceuticals, Inc. | AVIR | Grant | Stock Option (Right to Buy) | 61.3k | $6.50 | $398.2k | | 06/17/2022 |
06/14/2022 | Fusion Pharmaceuticals Inc. | FUSN | Grant | Stock Opion (Right to Buy) | 17k | $3.60 | $61.2k | | 06/14/2022 |
04/08/2022 | Ovid Therapeutics Inc. | OVID | Grant | Stock Option (Right to Buy) | 21.3k | $3.22 | $68.7k | | 04/08/2022 |
02/03/2022 | Ovid Therapeutics Inc. | OVID | Grant | Stock Option (Right to Buy) | 15k | $2.72 | $40.8k | | 02/03/2022 |
07/01/2021 | Adaptimmune Therapeutics PLC | ADAP | Grant | Option to purchase Ordinary Shares | 379.8k | $0.00 | $0 | | 07/01/2021 |
06/18/2021 | Jounce Therapeutics, Inc. | JNCE | Grant | Stock Option (Right to Buy) | 15.7k | $7.27 | $114.1k | | 06/18/2021 |
06/18/2021 | Atea Pharmaceuticals, Inc. | AVIR | Grant | Stock Option (Right to Buy) | 34k | $23.39 | $795.8k | | 06/18/2021 |
06/11/2021 | Ovid Therapeutics Inc. | OVID | Grant | Stock Option (Right to Buy) | 15k | $4.49 | $67.4k | | 06/11/2021 |
06/04/2021 | Fusion Pharmaceuticals Inc. | FUSN | Grant | Stock Opion (Right to Buy) | 17k | $8.15 | $138.6k | | 06/04/2021 |
05/17/2021 | Ovid Therapeutics Inc. | OVID | Grant | Stock Option (Right to Buy) | 1.8k | $3.67 | $6.4k | | 05/17/2021 |
10/30/2020 | Fusion Pharmaceuticals Inc. | FUSN | Grant | Stock Option (Right to Buy) | 30k | $12.40 | $372k | | 10/30/2020 |
10/29/2020 | Atea Pharmaceuticals, Inc. | AVIR | Grant | Stock Option (Right to Buy) | 80k | $24.00 | $1.9M | | 10/29/2020 |
10/23/2020 | IMMUNOMEDICS INC | IMMU | Disposition | Restricted Stock Unit | 3.7k | $0.00 | $0 | | 10/23/2020 |
10/23/2020 | IMMUNOMEDICS INC | IMMU | Disposition | Stock Option (Right to Buy) | 6.5k | $0.00 | $0 | | 10/23/2020 |
10/23/2020 | IMMUNOMEDICS INC | IMMU | Disposition | Common Stock | 49.2k | $0.00 | $0 | | 10/23/2020 |
09/15/2020 | Jounce Therapeutics, Inc. | JNCE | Exercise | Stock Option (Right to Buy) | 10k | $4.21 | $42.1k | | 09/15/2020 |
09/15/2020 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 5k | $9.50 | $47.5k | | 09/15/2020 |
09/15/2020 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 5k | $10.50 | $52.5k | | 09/15/2020 |
09/14/2020 | IMMUNOMEDICS INC | IMMU | Exercise | Stock Option (right to buy) | 2.5k | $16.96 | $42.4k | | 09/14/2020 |
08/17/2020 | IMMUNOMEDICS INC | IMMU | Exercise | Stock Option (right to buy) | 20k | $16.96 | $339.2k | | 08/17/2020 |
08/12/2020 | IMMUNOMEDICS INC | IMMU | Exercise | Stock Option (right to buy) | 17.1k | $12.93 | $220.8k | | 08/12/2020 |
07/01/2020 | Adaptimmune Therapeutics PLC | ADAP | Grant | Option to purchase Ordinary Shares | 144k | $0.00 | $0 | | 07/01/2020 |
06/26/2020 | Jounce Therapeutics, Inc. | JNCE | Grant | Stock Option (Right to Buy) | 15.7k | $7.58 | $119k | | 06/26/2020 |
06/26/2020 | Jounce Therapeutics, Inc. | JNCE | Grant | Stock Option (Right to Buy) | 13.6k | $7.58 | $102.7k | | 06/26/2020 |
06/18/2020 | IMMUNOMEDICS INC | IMMU | Grant | Common Stock, $0.01 par value per share | 3.7k | $0.00 | $0 | | 06/18/2020 |
06/18/2020 | IMMUNOMEDICS INC | IMMU | Grant | Stock Option (right to buy) | 6.5k | $33.62 | $219.9k | | 06/18/2020 |
06/05/2020 | Ovid Therapeutics Inc. | OVID | Grant | Stock Option (Right to Buy) | 13.2k | $5.29 | $70.1k | | 06/05/2020 |
02/03/2020 | Aevi Genomic Medicine, Inc. | CERC | Disposition | Common Stock | 59.5k | $0.00 | $0 | | 02/03/2020 |
02/03/2020 | Aevi Genomic Medicine, Inc. | CERC | Disposition | Stock Option (Right to Purchase) | 50k | $1.55 | $77.5k | | 02/03/2020 |
|